SERINC5 Is an Unconventional HIV Restriction Factor That Is Upregulated during Myeloid Cell Differentiation
Open Access
- 1 September 2020
- journal article
- research article
- Published by S. Karger AG in Journal of Innate Immunity
- Vol. 12 (5), 399-409
- https://doi.org/10.1159/000504888
Abstract
Classical antiviral restriction factors promote cellular immunity by their ability to interfere with virus replication and induction of their expression by proinflammatory cytokines such as interferons. The serine incorporator proteins SERINC3 and SERINC5 potently reduce the infectivity of HIV-1 particles when overexpressed, and RNA interference or knockout approaches in T cells have indicated antiviral activity also of the endogenous proteins. Due to lack of reagents for detection of endogenous SERINC proteins, it is still unclear whether SERINC3/5 are expressed to functionally relevant levels in different primary target cells of HIV infection and how the expression levels of these innate immunity factors are regulated. In the current study, analysis ofSERINC3/5mRNA steady-state levels in primary lymphoid and monocyte-derived cells revealed selective induction of their expression upon differentiation of myeloid cells. Contrary to classical antiviral restriction factors, various antiviral alpha-interferon subtypes and proinflammatory interleukins had no effect onSERINClevels, which were also not dysregulated in CD4+ T cells and monocytes isolated from patients with chronic HIV-1 infection. Notably, HIV-1 particles produced by terminally differentiated monocyte-derived macrophages with highSERINC5expression, but not by low-expressing monocytes, showed a Nef-dependent infectivity defect. Overall, these findings suggest endogenous expression of SERINC5 to antivirally active levels in macrophages. Our results classify SERINC5 as an unconventional HIV-1 restriction factor whose expression is specifically induced upon differentiation of cells towards the myeloid lineage.This publication has 30 references indexed in Scilit:
- Macrophages and their relevance in Human Immunodeficiency Virus Type I infectionRetrovirology, 2012
- Systematic identification of type I and type II interferon-induced antiviral factorsProceedings of the National Academy of Sciences of the United States of America, 2012
- IFN-γ-induced BST2 mediates monocyte adhesion to human endothelial cellsCellular Immunology, 2011
- The differential activity of interferon-α subtypes is consistent among distinct target genes and cell typesCytokine, 2011
- Host hindrance to HIV-1 replication in monocytes and macrophagesRetrovirology, 2010
- IL-27, a novel anti-HIV cytokine, activates multiple interferon-inducible genes in macrophagesAIDS, 2008
- Noninfectious papilloma virus–like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27Blood, 2006
- Serinc, an Activity-regulated Protein Family, Incorporates Serine into Membrane Lipid SynthesisOnline Journal of Public Health Informatics, 2005
- Rodent Cells Support Key Functions of the Human Immunodeficiency Virus Type 1 Pathogenicity Factor NefJournal of Virology, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001